Myeloid-Derived Growth Factor Ameliorates Tubulointerstitial Inflammation in Diabetic Kidney Disease
Inflammation · 16.11.2026
DOI: 10.1007/s10753-026-02648-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammation, online erschienen am 16.11.2026. Verfasst von Mingjuan He und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Nature Science Foundation of China.
Abstract (Originalsprache)
Tubulointerstitial inflammation plays an important role in the development of diabetic kidney disease (DKD), and tubular epithelial cells (TECs) act as a driving force in the inflammatory cascade. Our previous study showed that myeloid-derived growth factor (MYDGF) can attenuate podocyte injury and proteinuria in DKD mice. However, the role and regulation of MYDGF for tubulointerstitial inflammation in DKD remain unclear. Here, we found that myeloid cell-specific MYDGF deficiency exacerbated renal dysfunction, tubulointerstitial inflammation, and TEC injury, whereas restoring myeloid cell-derived MYDGF through bone marrow transplantation or myeloid cell-specific overexpression mitigated these effects in vivo. Functionally, MYDGF attenuated the inflammatory response and apoptosis in TECs induced by high glucose and palmitic acid, as demonstrated in both in vitro and ex vivo experiments. Mechanistically, the renoprotection of MYDGF involved down-regulation of the inhibitory kappa B kinase beta/nuclear factor-kappa B (IKKβ/NF-κB) pathway. Bidirectional functional assays in human kidney-2 (HK-2) cells further supported a key mediating role for IKKβ/NF‑κB signaling in MYDGF-conferred tubular protection. Thus, our studies suggest that myeloid cell-derived MYDGF is associated with the alleviation of tubulointerstitial inflammation and TEC injury in DKD, and that it may participate in bone marrow–kidney crosstalk.
Förderung
- the National Nature Science Foundation of China
Zitieren
APA
He, M., Mei, W., & Zhao, J. (2026). Myeloid-Derived Growth Factor Ameliorates Tubulointerstitial Inflammation in Diabetic Kidney Disease. Inflammation. https://doi.org/10.1007/s10753-026-02648-7
Vancouver
He M, Mei W, Zhao J. Myeloid-Derived Growth Factor Ameliorates Tubulointerstitial Inflammation in Diabetic Kidney Disease. Inflammation. 2026. doi:10.1007/s10753-026-02648-7
BibTeX
@article{He2026,
author = {He, Mingjuan and Mei, Wen and Zhao, Jingjing},
title = {Myeloid-Derived Growth Factor Ameliorates Tubulointerstitial Inflammation in Diabetic Kidney Disease},
journal = {Inflammation},
year = {2026},
doi = {10.1007/s10753-026-02648-7}
}
EUVIMED